Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S ADR
(NY:
NVO
)
143.81
-3.10 (-2.11%)
Streaming Delayed Price
Updated: 1:49 PM EDT, Jun 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
3,100,724
Open
145.56
Bid (Size)
143.80 (1)
Ask (Size)
143.82 (2)
Prev. Close
146.91
Today's Range
142.79 - 145.62
52wk Range
75.56 - 148.15
Shares Outstanding
N/A
Dividend Yield
1.23%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The Next 7 Trillion-Dollar Stocks to Buy: June 2024 Edition
Today 7:50 EDT
The next trillion dollar stocks have emerged in a few key areas that investors should understand in greater detail in order to profit.
Via
InvestorPlace
Better Growth Stock: Archer Aviation or Viking Therapeutics?
Today 7:45 EDT
Which one of these potential disruptors is the better buy?
Via
The Motley Fool
Performance
YTD
+40.84%
+40.84%
1 Month
+7.26%
+7.26%
3 Month
+11.13%
+11.13%
6 Month
+40.06%
+40.06%
1 Year
+82.94%
+82.94%
More News
Read More
Rivian, Lucid, Micron Technology, Novo Nordisk, Tesla: Why These 5 Stocks Are On Investors' Radars Today
June 25, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Novo Nordisk's Older Generation Weight-Loss Drug Saxenda Associated With Decreased Bone Mass Density, Study Shows
June 25, 2024
Via
Benzinga
Why Novo Nordisk Shares Are Trading Higher Tuesday
June 25, 2024
Via
Benzinga
A Closer Look at Novo Nordisk's Options Market Dynamics
June 25, 2024
Via
Benzinga
Novo Nordisk Wins Approval For Its Weight-Loss Drug From China
June 25, 2024
Via
Talk Markets
European Stocks Dip As US Market Sentiment Sours
June 25, 2024
Via
Talk Markets
Why Is Regis (RGS) Stock Up 215% Today?
June 25, 2024
Via
InvestorPlace
Jefferies Just Raised Its Price Target on Nvidia (NVDA) Stock
June 25, 2024
Via
InvestorPlace
Pfizer's Working on the Next Wegovy, but Can It Beat Novo Nordisk?
June 25, 2024
Via
The Motley Fool
NVO Stock: Novo Nordisk Pops as China Approves Wegovy Weight Loss Drug
June 25, 2024
Via
InvestorPlace
Novo Nordisk Surges Nearly 3% After Weight Loss Drug Wegovy Wins Approval in China
June 25, 2024
Via
Benzinga
Novartis Stock Just Below Innovative Drugmaker's All-Time High; Gets Key Rating Upgrade
June 25, 2024
Via
Investor's Business Daily
Wegovy, Ozempic Maker Novo Nordisk To Invest $4.1B In US Manufacturing, Doubling Plant Size To Meet Surging Demand For Weight Loss Drugs
June 25, 2024
Via
Benzinga
Regeneron Pharmaceuticals' Approach To Improve Quality Of Weight Loss Has Merit: Goldman Sachs
June 24, 2024
Via
Benzinga
Will Novo Nordisk Building Fires Serve As A Catalyst For Eli Lilly? Redditors See A Stock Split For US Company 'Very Likely'
June 24, 2024
Via
Benzinga
Exposures
Product Safety
ALT Stock Alert: Altimmune Pops on Weight-Loss Drug Findings
June 24, 2024
Via
InvestorPlace
7 Strong Buy Blue-Chip Stocks to Keep You in the Green
June 24, 2024
Via
InvestorPlace
Novo Nordisk's Wegovy Demonstrates Greater Weight Loss In Women With Heart Condition
June 24, 2024
Via
Benzinga
3 Biotech Stocks to Buy Now: June 2024
June 21, 2024
Via
InvestorPlace
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
June 21, 2024
Via
Benzinga
Lawsuit Could Challenge Trust In Ozempic And Other Popular Weight Loss Drugs
June 21, 2024
Via
Talk Markets
Topics
Lawsuit
Exposures
Financial
Legal
The Best Could Be Yet to Come for Novo Nordisk and Ozempic
June 21, 2024
Via
The Motley Fool
Move Aside Ozempic, WeGovy: Denmark's New Drug Just Showed Positive Results For Weightloss
June 21, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.